NET PROFIT (x1000 DKK)
EMPLOYEES
Frederiksstaden Pharma ApS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-51
|
-82
|
4 |
| Total assets |
407
|
328
|
264 |
| Current assets |
23
|
33
|
264 |
| Current liabilities |
309
|
180
|
33 |
| Equity capital |
98
|
149
|
231 |
| - share capital |
159
|
159
|
159 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
24.1%
|
45.4%
|
87.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
7.4%
|
18.3%
|
800% |
| Return on equity (ROE) |
-52.0%
|
-55.0%
|
1.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.